Medical Device News Magazine

Rhythm Management Group Launches RhythmSynergy™ Technology Platform

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

Rhythm Management Group, PLLC, has completed the launch of RhythmSynergy™, a powerful new technology platform that leverages machine-learning to efficiently deliver timely and relevant clinical insights for remotely monitored patients with implantable cardiac devices and wearable devices such as blood pressure cuffs, scales, and glucometers.

Recognized as one of the fastest growing companies in North America, Rhythm has more than a decade of experience centralizing and streamlining remote monitoring operational workflows for medical practices and health systems. It applied that knowledge to RhythmSynergy, focusing on features that enhance efficiency such as automated image processing and intuitive reporting.

“With over 10 years in the remote monitoring space and more than 100 years of combined clinical experience, we understand what staff and clinicians need from their remotely monitored data,” said Rhonda Bray, RN, Founder and CEO, Rhythm Management Group. “By extracting that information and providing clinically validated alerts, we accelerate risk identification so users of RhythmSynergy can provide more timely care.”

Key features of RhythmSynergy include:

  • Intuitive clinical and operational reporting
  • Automated image processing
  • Bi-directional EHR integration
  • Mobile and desktop optimized
  • Compliance with industry-leading security standards
  • Secure and scalable infrastructure

By combining clinical expertise and machine-learning technology, RhythmSynergy prioritizes critical information and streamlines review processes. Its sleek, secure design and powerful reporting tools make it easy to review, share, and analyze patient data. By employing automated data processing and real-time alerts, RhythmSynergy enables faster identification of patient health problems so physicians can intervene sooner.

Dr. John P. McKenzie, of Heartbeat Cardiovascular Medical Group, of Glendale, CA, a Rhythm customer, said, “Rhythm’s remote monitoring program, experienced clinical and engagement teams, and RhythmSynergy platform help us deliver better outcomes for patients without burdening our staff. The platform provides the data we need to make critical, informed care decisions, and optimizes data management by helping us achieve 90 percent remote monitoring penetration.”

The RhythmSynergy platform is available for both types of remote monitoring provided by Rhythm Management Group: Cardiac Rhythm Management (CRM) Monitoring, which is for patients with implantable cardiac devices, and Remote Physiologic Monitoring (RPM), which is for patients with smart health tech wireless devices like blood pressure cuffs, scales, and glucometers.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

Shoulder Innovations Further Strengthens IP Portfolio in Key Areas with Recent Patent Grants

"These recent grants further strengthen key patent families that are foundational to our technology, and we are pleased the USPTO continues to recognize our meaningful innovation in the shoulder arthroplasty segment," said Rob Ball, CEO of Shoulder Innovations. "This noteworthy expansion of our IP position represents the culmination of over 10 years of research and development, and we are proud of our team for their continued dedication to creating practical solutions for shoulder surgeons and advancing patient outcomes."

Radical Catheter Technologies Presents Analysis of Disruptive, Recently FDA-Cleared Endovascular Technology at the Society of NeuroInterventional Surgery 21st Annual Meeting

This new catheter, the first product commercialized from this novel technology platform, is designed to enable access to the blood vessels in the brain for both femoral and radial access. A multi-center analysis of this disruptive technology is being presented today at Society of NeuroInterventional Surgery 21st annual meeting. In addition, the Company confirmed the closing of a $20 million financing round led by NeuroTechnology Investors, which will be used to scale the company and expand the Radical platform notes Radical Catheter Technologies.

Rapid Medical™ Completes Initial Neurovascular Cases in the USA Following FDA Clearance of Its Active Access Solution

“With DRIVEWIRE, our design goal was to bring new levels of access and control to the interventional suite while improving best-in-class guidewires,” comments Giora Kornblau, Chief Technology Officer at Rapid Medical. “When physicians are looking for technologies that increase the clinical possibilities and safety for the patient, we want Rapid to be the first place they look.”